Regorafenib
Bayer
[]
a positive trial in later line #gastroesophageal is always an accomplishment. integrate iia meets primary os endpoint. #gi23 
GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School